PM

Palani Madesh

Active Director Director DIN 10111383
DIN 10111383 First appointment Apr 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Palani Madesh

Data last updated:

Palani Madesh is a Director at Medousa Healthcare Pharma Private Limited (since 2023). The company operates in Paper. Medousa Healthcare Pharma Private Limited reported revenue of ₹60,603 (FY 2024).

DIN 10111383
Primary Designation Director
Industry Paper
First Appointment 11 Apr 2023
Oldest Company Age 3 yrs
Largest company Medousa Healthcare Pharma Private Limited · ₹60,603 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Apr 20232023₹60,603 (FY 2024)Active

Board colleagues of Palani Madesh

Directorship timeline

Open interactive timeline →
Medousa Healthcare Pharma Private Limited
Premium access

Shareholding and investment profile for Palani Madesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Palani Madesh

Palani Madesh currently holds 1 directorship: Medousa Healthcare Pharma Private Limited (Director, since 11 Apr 2023, revenue ₹60,603 (FY 2024)).

Palani Madesh was first appointed on 11 Apr 2023 as Director at Medousa Healthcare Pharma Private Limited.

The current boards of Palani Madesh's companies include Arunpandiyan Soundarajan (Medousa Healthcare Pharma Private Limited), Ishaq Ahmad (Medousa Healthcare Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available